Bronchodilator and corticosteroid effects on regional and total airway resistance in patients with asthma, chronic bronchitis, and chronic pulmonary emphysema.
D000284:Administration, Oral; D000318:Adrenergic beta-Agonists / Q000627:therapeutic use; D000328:Adult; D000336:Aerosols; D000368:Aged; D000403:Airway Resistance / Q000187:drug effects*; D000605:Amino Alcohols / Q000627:therapeutic use; D001249:Asthma / Q000188:drug therapy*; D001991:Bronchitis / Q000188:drug therapy*; D001993:Bronchodilator Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D002000:Bronchospirometry; D002396:Catechols / Q000627:therapeutic use; D005260:Female; D006634:Histamine H1 Antagonists / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008875:Middle Aged; D010656:Phenylephrine / Q000008:administration & dosage / Q000627:therapeutic use; D010993:Plethysmography, Whole Body; D011241:Prednisone / Q000008:administration & dosage / Q000627:therapeutic use*; D011437:Propylamines / Q000627:therapeutic use; D011656:Pulmonary Emphysema / Q000188:drug therapy*; D012123:Pulmonary Ventilation / Q000187:drug effects; D011725:Pyridines / Q000627:therapeutic use; D011868:Radioisotopes; D012129:Respiratory Function Tests; D014978:Xenon
D000318:Adrenergic beta-Agonists; D000336:Aerosols; D000605:Amino Alcohols; D001993:Bronchodilator Agents; D002396:Catechols; D006634:Histamine H1 Antagonists; D011437:Propylamines; D011725:Pyridines; D011868:Radioisotopes; D010656:Phenylephrine; D014978:Xenon; D011241:Prednisone